用于化疗的完全植入式中心静脉导管：793例患者的经验

Totally implantable central venous catheters for chemotherapy: experience with 793 patients.

作者信息

de Oliveira Esmálio Barroso, Reis Maurício Aguiar, Avelar Tiago Marques, Vieira Sabas Carlos

机构信息

Universidade Federal do Piauí, Piauí State - PI, Brazil.

出版信息

Rev Col Bras Cir. 2013 May-Jun;40(3):186-90. doi: 10.1590/s0100-69912013000300004.

DOI:10.1590/s0100-69912013000300004

PMID:23912364

Abstract

OBJECTIVE

To retrospectively study the results obtained with the implementation of totally implantable catheters in patients undergoing chemotherapy.

METHODS

815 totally implantable catheters placed in 793 patients undergoing chemotherapy regimen, preferably using the right cephalic vein. We evaluated early and late complications.

RESULTS

The retrospective analysis showed an average duration of 339 days of the catheters. In 733 (90%) catheters there was no observe complication. Among early complications we observed one pneumothorax, one bad positioning of the catheter, one arterial puncture, one bleeding, one hemothorax and hemomediastinum and six hematomas in the implantation site. As for late complications, there were 35 catheter-related infections ten, infections in the surgical site, six obstructions and 20 thromboses. We removed 236 catheters, 35 due to complications and 201 by the end of treatment.

CONCLUSION

totally implantable catheters for chemotherapy are a safe means for the administration of substances, in view of the low number of complications observed in this study.

摘要

目的

回顾性研究在接受化疗的患者中植入全植入式导管的结果。

方法

在793例接受化疗方案的患者中放置了815根全植入式导管，首选使用右侧头静脉。我们评估了早期和晚期并发症。

结果

回顾性分析显示导管的平均使用时长为339天。733根（90%）导管未观察到并发症。在早期并发症中，我们观察到1例气胸、1例导管位置不当、1例动脉穿刺、1例出血、1例血胸和纵隔积血以及6例植入部位血肿。至于晚期并发症，有35例导管相关感染、10例手术部位感染、6例堵塞和20例血栓形成。我们拔除了236根导管，其中35根因并发症拔除，201根在治疗结束时拔除。